Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver

Journal of Lipid Research

Volumn 56, Issue 7, 2015, Pages 1329-1339

  Gu, Jin ^a   Zhang, Yongxian ^a   Xu, Daqian ^a   Zhao, Zilong ^a   Zhang, Yuxue ^a   Pan, Yi ^a   Cao, Peijuan ^a   Wang, Zhenzhen ^a   Chen, Yan ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Fatty liver; Glycogen synthase; Lipid metabolism; Sterol regulatory element binding protein; Supplementary alcoholic liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; GLYCOGEN; LIPID; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 3G; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLIC FATTY LIVER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BINGE DRINKING; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; IN VIVO STUDY; LIPID STORAGE; LIPOGENESIS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTIBODY SPECIFICITY; CELL LINE; DRUG EFFECTS; FATTY LIVER, ALCOHOLIC; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; ETHANOL; FATTY LIVER, ALCOHOLIC; FEMALE; GLYCOGEN; LIPID METABOLISM; LIVER; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROTEIN PHOSPHATASE 1;

EID: 84937130946     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M056978     Document Type: Article

References (27)

1. Rehm, J., C. Mathers, S. Popova, M. Thavorncharoensap, Y. Teerawattananon, and J. Patra. 2009. Global burden of disease and injury and economic cost attributable to alcohol use and alcoholuse disorders. Lancet. 373: 2223-2233.
2. Gao, B., and R. Bataller. 2011. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 141: 1572-1585.
3. Orman, E. S., G. Odena, and R. Bataller. 2013. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J. Gastroenterol. Hepatol. 28 (Suppl 1): 77-84.
4. Lieber, C. S., D. P. Jones, and L. M. Decarli. 1965. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J. Clin. Invest. 44: 1009-1021.
5. Baraona, E., and C. S. Lieber. 1979. Effects of ethanol on lipid metabolism. J. Lipid Res. 20: 289-315.
6. You, M., M. Fischer, M. A. Deeg, and D. W. Crabb. 2002. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277: 29342-29347.
7. Ji, C., C. Chan, and N. Kaplowitz. 2006. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J. Hepatol. 45: 717-724.
8. Galli, A., J. Pinaire, M. Fischer, R. Dorris, and D. W. Crabb. 2001. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J. Biol. Chem. 276: 68-75.
9. Shoemaker, W. C., and D. H. Elwyn. 1969. Liver: functional interactions within the intact animal. Annu. Rev. Physiol. 31: 227-268.
10. Hers, H. G. 1976. The control of glycogen metabolism in the liver. Annu. Rev. Biochem. 45: 167-189.
11. Moore, M. C., A. D. Cherrington, and D. H. Wasserman. 2003. Regulation of hepatic and peripheral glucose disposal. Best Pract. Res. Clin. Endocrinol. Metab. 17: 343-364.
12. Agius, L. 2008. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem. J. 414: 1-18.
13. Ceulemans, H., and M. Bollen. 2004. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84: 1-39.
14. Munro, S., H. Ceulemans, M. Bollen, J. Diplexcito, and P. T. Cohen. 2005. A novel glycogen-targeting subunit of protein phosphatase 1 that is regulated by insulin and shows differential tissue distribution in humans and rodents. FEBS J. 272: 1478-1489.
15. Luo, X., Y. Zhang, X. Ruan, X. Jiang, L. Zhu, X. Wang, Q. Ding, W. Liu, Y. Pan, Z. Wang, et al. 2011. Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis. Diabetes. 60: 1435-1445.
16. Zhang, Y., D. Xu, H. Huang, S. Chen, L. Wang, L. Zhu, X. Jiang, X. Ruan, X. Luo, P. Cao, et al. 2014. Regulation of glucose homeostasis and lipid metabolism by PPP1R3G-mediated hepatic glycogenesis. Mol. Endocrinol. 28: 116-126.
17. Liu, G., Y. Zhang, C. Liu, D. Xu, R. Zhang, Y. Cheng, Y. Pan, C. Huang, and Y. Chen. 2014. Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice. J. Nutr. 144: 1009-1015.
18. Bertola, A., S. Mathews, S. H. Ki, H. Wang, and B. Gao. 2013. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat. Protoc. 8: 627-637.
19. Frolow, J., and C. L. Milligan. 2004. Hormonal regulation of glycogen metabolism in white muscle slices from rainbow trout (Oncorhynchus mykiss Walbaum). Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R1344-R1353.
20. Tang, J. J., J. G. Li, W. Qi, W. W. Qiu, P. S. Li, B. L. Li, and B. L. Song. 2011. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 13: 44-56.
21. Fruchart, J. C. 2009. Peroxisome proliferator-activated receptoralpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease. Atherosclerosis. 205: 1-8.
22. Filhoulaud, G., S. Guilmeau, R. Dentin, J. Girard, and C. Postic. 2013. Novel insights into ChREBP regulation and function. Trends Endocrinol. Metab. 24: 257-268.
23. Petrasek, J., S. Bala, T. Csak, D. Lippai, K. Kodys, V. Menashy, M. Barrieau, S. Y. Min, E. A. Kurt-Jones, and G. Szabo. 2012. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122: 3476-3489.
24. Liangpunsakul, S., R. A. Ross, and D. W. Crabb. 2013. Activation of carbohydrate response element-binding protein by ethanol. J. Investig. Med. 61: 270-277.
25. Marmier, S., R. Dentin, M. Daujat-Chavanieu, H. Guillou, J. Bertrand-Michel, S. Gerbal-Chaloin, J. Girard, S. Lotersztajn, and C. Postic. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology. Epub ahead of print. March 11, 2015; doi:10.1002/hep.27778.
26. Tsai, W. W., S. Matsumura, W. Liu, N. G. Phillips, T. Sonntag, E. Hao, S. Lee, T. Hai, and M. Montminy. 2015. ATF3 mediates inhibitory effects of ethanol on hepatic gluconeogenesis. Proc. Natl. Acad. Sci. USA. 112: 2699-2704.
27. Ou, J., H. Tu, B. Shan, A. Luk, R. A. DeBose-Boyd, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98: 6027-6032.